DLHIX Holdings Information

DLHIX is a mutual fund with a total of 108 individual holdings. The top holdings are UCB SA stock at 5.20%, AbbVie at 4.20%, Eli Lilly and Company at 4.17%, Regeneron Pharmaceuticals at 3.91%, and UnitedHealth Group at 3.89%.

Total Holdings

108

Top 10 Percentage

38.98%

Asset Class

Equity

Fund Category

Health

Assets

745.76M

Forward PE Ratio

14.84

Breakdown by Asset Class

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	EBR: UCB	UCB SA	5.20%	130,137
2	ABBV	AbbVie Inc.	4.20%	125,000
3	LLY	Eli Lilly and Company	4.17%	26,000
4	REGN	Regeneron Pharmaceuticals, Inc.	3.91%	47,000
5	UNH	UnitedHealth Group Incorporated	3.89%	70,000
6	PFE	Pfizer Inc.	3.84%	1,195,000
7	MRK	Merck & Co., Inc.	3.69%	215,000
8	GILD	Gilead Sciences, Inc.	3.54%	210,000
9	LON: AZN	AstraZeneca PLC	3.27%	131,243
10	ELV	Elevance Health, Inc.	3.25%	63,000
11	SWX: ROP	Roche Holding AG	3.02%	55,000
12	TYO: 4519	Chugai Pharmaceutical Co., Ltd.	2.78%	450,000
13	VTRS	Viatris Inc.	2.48%	1,170,018
14	ORKA	Oruka Therapeutics, Inc.	2.42%	190,000
15	HALO	Halozyme Therapeutics, Inc.	2.30%	220,000
16	AMGN	Amgen Inc.	2.27%	47,000
17	ILMN	Illumina, Inc.	2.11%	90,000
18	ALKS	Alkermes plc	1.82%	260,000
19	VKTX	Viking Therapeutics, Inc.	1.72%	330,100
20	VRTX	Vertex Pharmaceuticals Incorporated	1.66%	25,000
21	ROIV	Roivant Sciences Ltd.	1.60%	338,181
22	NBIX	Neurocrine Biosciences, Inc.	1.58%	70,000
23	RCUS	Arcus Biosciences, Inc.	1.56%	379,100
24	ZBH	Zimmer Biomet Holdings, Inc.	1.43%	124,000
25	BSX	Boston Scientific Corporation	1.43%	250,000

Showing 25 of 108 holdings

Subscribe to see the full list

Activate Now

As of Jun 30, 2026